Evidence map›Paper›PMID 40385770›Full record

ArticleCureus2025

Mitral Valve Aneurysm With Severe Mitral Regurgitation and Pseudoaneurysm Formation: A Rare Complication of Infective Endocarditis.

Kesar Prajapati, Fnu Samaksh, Poornima Jaiswal Charpuria, Nisarg Desai, Ankit V Shah

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kesar PrajapatiInternal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Fnu SamakshInternal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Poornima Jaiswal CharpuriaInternal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Nisarg DesaiCardiology, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, IND.
Ankit V ShahCardiology, University of Pittsburgh Medical Center (UPMC) Harrisburg, Harrisburg, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infective endocarditis (IE) is a life-threatening condition caused by infection of the heart's endocardial surface, often involving native or prosthetic valves. It presents with diverse symptoms, ranging from isolated fever and heart failure to more severe manifestations such as ischemic stroke from septic or thrombus embolization. A rare but serious complication of IE is mitral valve aneurysm (MVA), a localized outpouching of the mitral valve, often leading to mitral regurgitation (MR), heart failure, and, in severe cases, rupture. This report highlights a case of delayed diagnosis of IE in a 34-year-old female who presented with prolonged fever, progressive dyspnea, and signs of heart failure. Echocardiography revealed severe MR, anterior mitral valve leaflet perforation, and a large pseudoaneurysm, suggesting MVA. Because of the advanced presentation, the patient developed refractory heart failure and electrical storm, leading to a fatal outcome before surgery could be performed. This case underscores the importance of early recognition of IE and MVA and the challenges in managing complicated cases, where mitral valve replacement is the preferred surgical option. Early diagnosis and timely intervention are crucial to prevent severe complications and improve prognosis.

Indexed as

echocardiography - heart failure - valvular heart diseaseheart failureinfective endocarditismitral regurgitationmitral valve aneurysm

Identifiers

PMID40385770
PMCPMC12085972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.